Pages that link to "Q34506495"
Jump to navigation
Jump to search
The following pages link to Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations (Q34506495):
Displaying 50 items.
- Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer (Q27009306) (← links)
- The disparate origins of ovarian cancers: pathogenesis and prevention strategies. (Q30240709) (← links)
- A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study (Q30431721) (← links)
- A novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing. (Q33214483) (← links)
- "Back to a false normality": new intriguing mechanisms of resistance to PARP inhibitors (Q33618910) (← links)
- Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry? (Q33687535) (← links)
- Hereditary Breast-Ovarian Cancer Team of the University Medical Centre Groningen (UMCG) - a Report (Q33721575) (← links)
- Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer. (Q33919065) (← links)
- Emerging roles of BRCA1 alternative splicing (Q33919195) (← links)
- Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy (Q34126089) (← links)
- Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up (Q34313361) (← links)
- 10 rare tumors that warrant a genetics referral. (Q34325954) (← links)
- Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. (Q34519901) (← links)
- The incidence of primary fallopian tube cancer in the United States (Q34706823) (← links)
- Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management (Q34977063) (← links)
- Cancer risk assessment for the primary care physician (Q34992880) (← links)
- The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers (Q35018746) (← links)
- The fallopian tube: from back stage to center stage (Q35562911) (← links)
- Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. (Q35758403) (← links)
- Asymptomatic primary fallopian tube cancer: an unusual cause of axillary lymphadenopathy (Q35910080) (← links)
- Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations (Q35934073) (← links)
- Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations (Q36111438) (← links)
- Surveillance of women at high risk for hereditary ovarian cancer is inefficient (Q36614506) (← links)
- Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004. (Q37252742) (← links)
- Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations (Q37356474) (← links)
- Pathogenesis and heterogeneity of ovarian cancer. (Q37546692) (← links)
- The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift (Q38187331) (← links)
- Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition. (Q38451794) (← links)
- Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin? (Q38693040) (← links)
- Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery (Q38732720) (← links)
- Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention (Q39441988) (← links)
- FANCD2 protein is expressed in proliferating cells of human tissues that are cancer‐prone in Fanconi anaemia (Q40630222) (← links)
- Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry (Q43625600) (← links)
- Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary (Q46904235) (← links)
- Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study. (Q47427859) (← links)
- Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy. (Q50697654) (← links)
- Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer (Q50760539) (← links)
- Primary transitional cell carcinoma of the fallopian tube (Q51434193) (← links)
- A meta-analysis of biomarkers for the prognosis of triple-negative breast cancer patients (Q51684386) (← links)
- HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study. (Q54005783) (← links)
- Ki-67 and p53 expression of the fallopian tube mucosa in breast cancer patients with hereditary risk. (Q54653872) (← links)
- A novel Q3034R BRCA2 germline mutation identified in a fallopian tube cancer patient. (Q54786138) (← links)
- Pathology of hereditary breast cancer. (Q55110010) (← links)
- Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube. (Q55397998) (← links)
- Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility? (Q59159730) (← links)
- Cell Origins of High-Grade Serous Ovarian Cancer (Q59809876) (← links)
- Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous Carcinogenesis (Q60931084) (← links)
- Incidence of intraepithelial fallopian tube neoplasias in mexican women over 40 years of age that underwent elective hysterectomy. (Q64922061) (← links)
- Tubal ligation and risk of ovarian cancer (Q74550974) (← links)
- Occult cancer of the fallopian tube in a BRCA2 germline mutation carrier at prophylactic salpingo-oophorectomy (Q76383194) (← links)